Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Ayurvedic treatment with Gandharvahastadi Kwath improved thyroid dysfunction symptoms.

Kerion cases had longer disease duration but responded well to antifungal treatments.

Traditional Persian medicine helped a woman with resistant hyperthyroidism improve and stabilize her condition.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Abnormal T-cells from thymomas cause non-motor symptoms in some myasthenia gravis patients.

Thyroid hormones help hair grow, reduce hair loss, and increase hair pigment.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Thyroid-stimulating hormone affects hair follicles but doesn't change hair growth or color.

Fractional infrared technology is effective and safe for treating cervical laxity.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

KLHL24-mutant stem cells help understand skin and heart disease.

Recognizing macro-TSH is crucial to avoid unnecessary treatments.

Abatacept may help some people with alopecia areata regrow hair.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Gray hair regained color after thyroid hormone treatment.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

Tofacitinib treatment is used for teenagers with alopecia areata.

Recent legal rulings favored Genentech, Teva, and upheld guidelines for patent term extensions.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Microbeam Radiation Therapy is effective, but using a linear accelerator reduces its benefits.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.